Expert Insight into the 2016 ASCO Updates for Metastatic Pancreatic Cancer

You need to be logged in to continue. Please Log In or Register using the box at the top right of this page.

Release Date: September 16, 2016
Expiration Date: September 16, 2017

Expected time to complete this activity as designed: 15 minutes

There are no fees for participating in or receiving credit for this online activity.

Program Overview

In 2015, the American Society of Clinical Oncology (ASCO) initiated a Pancreatic Cancer Working Group to help standardize the care of patients with pancreatic cancer. At that time, three expert panels convened to address the three most common clinical presentations for pancreatic cancer, which were published in the Journal of Clinical Oncology between July and August of 2016. In a recent interview, Dr. Alok Khorana, Professor of Medicine and Director of the Gastrointestinal Malignancies Program at the Cleveland Clinic, provided an overview of the recently released guidelines for the management of potentially curable, locally advanced/unresectable, and metastatic pancreatic cancer to assist health care providers in their application of clinical recommendations to practice.

Target Audience

This activity is designed for community oncologists, pharmacists, and allied health care professionals who may provide care to patients with pancreatic cancer.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Summarize the initial treatment recommendations from the 2016 American Society of Clinical Oncology (ASCO) guidelines for potentially curable, locally advanced/unresectable, and metastatic pancreatic cancer


Expert Insight into the 2016 ASCO Updates for Metastatic Pancreatic Cancer – Alok A. Khorana, MD

Instructions for Participation and Credit

This activity is eligible for credit through September 16, 2017. After this date, this activity will expire and no further credit will be awarded.
1. Read the target audience, learning objectives, and faculty disclosures.
2. You may be asked to complete a short pre-test before accessing the educational content. This must be completed in order to move forward in the activity.
3. Complete the educational content as designed.
4. Complete the post-test. To receive a certificate, you must receive a passing score of 70%.
5. Complete the activity evaluation survey to provide feedback and information useful for future programming.
6. Certificates for CME credit may be printed immediately after successfully completing the post-test and activity evaluation. Pharmacist credit will be uploaded to CPE Monitor 4 weeks following receipt of a completed, qualified form.

Faculty Biography

Alok A. Khorana, MD
Sondra and Stephen Hardis Chair in Oncology Research
Director, Gastrointestinal Malignancies Program
Taussig Cancer Institute
Cleveland Clinic
Cleveland, Ohio

Dr. Alok Khorana received his medical degree from Maharaja Sayajirao University’s Medical College in Baroda (Gujarat), India. His postdoctoral training included a residency in internal medicine at the University at Buffalo in New York, and a fellowship in hematology/oncology at the University of Rochester. He is a fellow of the American College of Physicians. Dr. Khorana is the Sondra and Stephen Hardis Chair in Oncology Research and Director of the Gastrointestinal Malignancies Program at Taussig Cancer Institute of the Cleveland Clinic. His clinical and translational research program focuses on predictive factors in gastrointestinal cancers and cancer-associated thrombosis, and has been funded by grants from the National Cancer Institute, the National Heart, Lung, and Blood Institute, and the V Foundation for Cancer Research.

Dr. Khorana serves on the American Society of Clinical Oncology (ASCO) Clinical Practice Guidelines Panel, the ASCO Scientific Program Committee and the GI committees of the Southwest Oncology Group and American College of Surgeons Oncology Group. He is current chair of the International Society on Thrombosis and Haemostasis Scientific Subcommittee on Hemostasis and Malignancy and has previously served as a member of the US Pharmacopoeia Oncology Expert Committee. Co-editor of the book Cancer-Associated Thrombosis: New Findings in Translational Science, Prevention and Treatment, Dr. Khorana’s scientific work has been published in a variety of scientific journals, including Journal of Clinical Oncology, Blood, Clinical Cancer Research, and Archives of Internal Medicine. He is an associate editor of the journal Cancer Investigation and has co-authored chapters in multiple textbooks including Cecil Essentials of Medicine and DeVita’s Cancer: Principles and Practice of Oncology.


MediCom WOrldwide, Inc. CME CREDIT
Accreditation Statement: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is acceptable for 0.25 contact hours of Continuing Education Credit. Universal Activity Number: 0827-0000-16-110-H01-P. Knowledge-based CPE activity.

In order for CPE Monitor to authenticate credit, pharmacists/technicians must provide their e-Profile ID number from NABP and date of birth (in MMDD format) when registering for a CPE program. Please make sure to provide this information in your Member Profile accessed through the login/registration on the home page of this site.


As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE) and California State Board of Registered Nursing, MediCom Worldwide, Inc. requires everyone who is in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest. Accordingly, the following disclosures were made.

Faculty Disclosure

Dr. Alok Khorana has received honoraria related to formal advisory activities from Janssen Pharmaceuticals, Inc. and Pfizer Inc., and consultant fees from F. Hoffmann-La Roche Ltd. and Sanofi. He has received grant support related to research activities from Janssen and LEO Pharma Inc.

Planning Committee Disclosures

The individuals listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, RN, MHA, Executive Director, has no relevant financial relationships.

Peer Reviewer Disclosure

In accordance with MediCom Worldwide, Inc. policy, all content is independently peer reviewed for balance, objectivity and commercial bias. The peer reviewers have no relevant financial relationships to disclose.

Physician Payments, Sunshine Act

MediCom Worldwide, Inc. complies with the Physician Payments Sunshine Act as part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfer of value provided to any covered recipient under the ACA.

Hardware/Software/Internet Requirements

MediCom Worldwide, Inc. requires Internet Explorer® version 9.0 or higher, the latest version of Google Chrome, or the latest version of Safari, a computer running Windows® Vista, Windows® 7, or Mac OS X, 512MB of RAM or greater, 1.5 GHZ or faster processor, and a screen resolution of 1024x768 or higher. Certain educational activities may require additional software to view. These activities will be marked with the information and/or links to the required software. That software may include Adobe® Flash® Player, Adobe® Acrobat®, Windows Media® Player, and/or Microsoft® Silverlight™.

If you have any questions or concerns regarding this activity, please contact MediCom Worldwide, Inc. at 1-800-408-4242 or email us at

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Celgene Corporation and Incyte Corporation.

©2016 MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067, 800-408-4242.
No portion of this material may be copied or duplicated without the expressed permission of MediCom Worldwide, Inc.

You need to be logged in to continue. Please Log In or Register using the box at the top right of this page.

MediCom Worldwide, Inc. would like to thank Celgene Corporation for their educational support of

©2020 MediCom Worldwide, Inc. All rights reserved